Fred Alger Management’s Cidara Therapeutics CDTX Stock Holding History

Fred Alger Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-164,575	Closed	-$36.4M	–	457
2025 Q4	$36.4M	Sell	164,575 -338,302	-67%	-$54.7M	0.14%	82
2025 Q3	$48.2M	Buy	+502,877	New	+$32.1M	0.19%	64

Fred Alger Management's CDTX Position: Q1 2026 in Review

Fred Alger Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 164,575 shares — an estimated $36.4M sold.

Fred Alger Management first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $48.2M in Q3 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Fred Alger Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Fred Alger Management sold 164,575 Cidara Therapeutics shares in Q1 2026, an estimated $36.4M.
Fred Alger Management first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Fred Alger Management's Cidara Therapeutics position peaked at $48.2M in Q3 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.